Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial.
APA
Inoue T, Kato A, et al. (2025). Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial.. Hepatobiliary surgery and nutrition, 14(4), 673-675. https://doi.org/10.21037/hbsn-2025-315
MLA
Inoue T, et al.. "Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial.." Hepatobiliary surgery and nutrition, vol. 14, no. 4, 2025, pp. 673-675.
PMID
40893742
같은 제1저자의 인용 많은 논문 (5)
- Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter study.
- Report of the Advanced Prostate Cancer Consensus Conference-JAPAN 2025 at the 112 Annual Meeting of the Japanese Urological Association.
- Biliary Drainage During Neoadjuvant Chemotherapy in Pancreatic Cancer: Evidence and Practical Recommendations.
- Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan.
- Restoration of the gut-microbiota-liver axis after hepatitis C virus eradication.